BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Aileron Therapeutics 

281 Albany Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-995-0900 Fax: 617-995-2410


SEARCH JOBS



Segment
Pharmaceuticals





 Company News
Aileron Therapeutics To Present At Cowen and Company 34th Annual Health Care Conference On March 4, 2014 3/3/2014 7:24:28 AM    More...
Aileron Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/10/2014 10:10:09 AM    More...
Aileron Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/10/2014 9:39:45 AM    More...
Big Pharma Quartet Dumps $30 Million Behind Aileron Therapeutics' P53 Peptide Drug 11/18/2013 8:07:26 AM    More...
Aileron Therapeutics Publishes Data Demonstrating ATSP-7041 as First-in-class p53 Pathway Re-activator for the Treatment of Solid and Hematologic Cancers 8/15/2013 10:45:31 AM    More...
Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial 5/7/2013 11:01:34 AM    More...
Aileron Therapeutics Presents New Preclinical Data on Stapled Peptide Inhibitor of Cancer Transcription Factor HIF-1a at American Association for Cancer Research Annual Meeting 4/10/2013 6:59:16 AM    More...
Aileron Therapeutics Presents New Data on Stapled Peptide Oncology Program at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics 11/7/2012 9:20:19 AM    More...
Aileron Therapeutics to Present at Upcoming Scientific Conferences and Industry Events 10/31/2012 7:39:13 AM    More...
Aileron Therapeutics Unveils New Therapeutic Drug Program; Appoints Hubert C. Chen, M.D., to Vice President of Clinical Development 9/6/2012 10:18:00 AM    More...
123

//-->